Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 1:40 AM
Ignite Modification Date: 2025-12-25 @ 11:56 PM
NCT ID: NCT04606394
Description: No difference in definitions
Frequency Threshold: 0
Time Frame: 6 weeks - from consent to 1 week post completion of study
Study: NCT04606394
Study Brief: Peak Inspiratory Flow and Dry Powder Inhaler Performance in COPD
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Open Label Treatment All subjects receive Trelegy and Ventolin for 2 weeks Trelegy Ellipta 100/62.5/25Mcg Inh 30D: Administration of Trelegy in all patients Ventolin 90Mcg/Actuation Inhalation Aerosol: 2 hours after the administration of Trelegy, administer Ventolin in all patients 0 None 0 45 0 45 View
Serious Events(If Any):
Other Events(If Any):